Skip to content
Disclosery

CITADEL ADVISORS LLC: MED position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CITADEL ADVISORS LLC on MED, newest first. How the timeline and the estimate are built.

CITADEL ADVISORS LLC held 56,350 MED shares at 2026-06-30 per its 13F-HR/A filed 2026-09-02.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F/A 56,350 shares
    Change vs previous 13F +56,350 shares

    <0.01% of the 13F portfolio, value $597,873.

    13F-HR/A 0001104659-26-104387 filed by CITADEL ADVISORS LLC
    Accepted , ingested

  2. period ended2025-06-30
    13F 0 shares
    Change vs previous 13F -56,662 shares

    13F-HR 0001104659-25-078555 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  3. period ended2025-03-31
    13F 56,662 shares
    Change vs previous 13F +23,504 shares

    <0.01% of the 13F portfolio, value $763,804.

    13F-HR 0000950123-25-005687 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 33,158 shares
    Change vs previous 13F +30,112 shares

    <0.01% of the 13F portfolio, value $584,244.

    13F-HR 0000950123-25-002739 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 3,046 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $58,300.

    13F-HR 0000950123-24-011767 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).